Evaluation of the Efficacy of Different Non-Surgical Peri-implantitis Treatment Approaches
Clinical and Biochemical Evaluation of the Efficacy of Different Non-Surgical Peri-implantitis Treatment Approaches
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Meltem Ozdemir Kabalak
- Phone Number: +905377921064
- Email: dt.meltemozdemir@gmail.com
Study Locations
-
-
-
Ankara, Turkey (Türkiye), 06100
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Who have not received any periodontal treatment in the last 6 months,
- Who have not used any medication (antibiotics, anti-inflammatory drugs, antibacterial mouthwashes, corticosteroids) that could affect the results of the study in the last 3 months,
- Who have at least one implant with a probing depth of 6 mm or deeper in one or more areas in the mouth, and the implant in question has been in function for at least 1 year,
- Between the ages of 18-65,
- Individuals who approve the informed consent form will be included in the study.
Exclusion Criteria:
Individuals who:
- have a systemic disease that may affect the periodontium,
- regularly use medication that may affect the periodontium,
- smoke,
- are pregnant or lactating,
- are sensitive to chlorhexidine,
- have more than 50% bone loss around their current implant(s),
- do not approve the informed consent form will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Treatment of peri-implantitis using titanium curette
Non-surgical peri-implantitis treatment will be performed using titanium curettes suitable for use on implant surfaces
|
Titanium curette will be used for non-surgical treatment of peri-implantitis
|
|
Experimental: Treatment of peri-implantitis using Airflow device
Non-surgical peri-implantitis treatment will be performed using erythritol powder with Airflow device
|
Airflow device with erythritol powder will be used in the treatment of non-surgical peri-implantitis
|
|
Experimental: Treatment of peri-implantitis using titanium curette + Airflow device
Non-surgical peri-implantitis treatment will be performed using titanium curette and erythritol powder with Airflow device
|
Titanium curette will be used for non-surgical treatment of peri-implantitis
Airflow device with erythritol powder will be used in the treatment of non-surgical peri-implantitis
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probing Depth
Time Frame: From enrollment to the 6 months after treatment.
|
The distance between the gingival margin and the base of the pocket will be measured with a periodontal probe.
|
From enrollment to the 6 months after treatment.
|
|
Bleeding on probing
Time Frame: From enrollment to the 6 months after treatment
|
Bleeding occurring within 10 seconds after probing will be evaluated as dichotomous (+/-).
|
From enrollment to the 6 months after treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
IL-10, RANKL, OPG, TWEAK, and IL-17
Time Frame: 3rd and 6th months after treatment
|
IL-10, RANKL, OPG, TWEAK, and IL-17 levels will be analyzed by ELISA test.
|
3rd and 6th months after treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- THD-2023-20873
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.